COGT
Price
$13.05
Change
+$0.11 (+0.85%)
Updated
Sep 5 closing price
Capitalization
1.82B
72 days until earnings call
FGEN
Price
$12.10
Change
+$0.79 (+6.98%)
Updated
Sep 5 closing price
Capitalization
48.93M
Interact to see
Advertisement

COGT vs FGEN

Header iconCOGT vs FGEN Comparison
Open Charts COGT vs FGENBanner chart's image
Cogent Biosciences
Price$13.05
Change+$0.11 (+0.85%)
Volume$1.85M
Capitalization1.82B
FibroGen
Price$12.10
Change+$0.79 (+6.98%)
Volume$40.78K
Capitalization48.93M
COGT vs FGEN Comparison Chart in %
Loading...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COGT vs. FGEN commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a Hold and FGEN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (COGT: $13.05 vs. FGEN: $12.10)
Brand notoriety: COGT and FGEN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 66% vs. FGEN: 73%
Market capitalization -- COGT: $1.82B vs. FGEN: $48.93M
COGT [@Biotechnology] is valued at $1.82B. FGEN’s [@Biotechnology] market capitalization is $48.93M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 0 FA rating(s) are green whileFGEN’s FA Score has 0 green FA rating(s).

  • COGT’s FA Score: 0 green, 5 red.
  • FGEN’s FA Score: 0 green, 5 red.
According to our system of comparison, FGEN is a better buy in the long-term than COGT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 4 TA indicator(s) are bullish while FGEN’s TA Score has 5 bullish TA indicator(s).

  • COGT’s TA Score: 4 bullish, 3 bearish.
  • FGEN’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both COGT and FGEN are a good buy in the short-term.

Price Growth

COGT (@Biotechnology) experienced а +8.03% price change this week, while FGEN (@Biotechnology) price change was +2.28% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

COGT is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COGT($1.82B) has a higher market cap than FGEN($48.9M). COGT YTD gains are higher at: 67.308 vs. FGEN (-8.593). FGEN has higher annual earnings (EBITDA): -77.3M vs. COGT (-299.34M). COGT has more cash in the bank: 238M vs. FGEN (23.4M). COGT has less debt than FGEN: COGT (60.7M) vs FGEN (73.7M). FGEN has higher revenues than COGT: FGEN (7.35M) vs COGT (0).
COGTFGENCOGT / FGEN
Capitalization1.82B48.9M3,728%
EBITDA-299.34M-77.3M387%
Gain YTD67.308-8.593-783%
P/E RatioN/AN/A-
Revenue07.35M-
Total Cash238M23.4M1,017%
Total Debt60.7M73.7M82%
FUNDAMENTALS RATINGS
COGT vs FGEN: Fundamental Ratings
COGT
FGEN
OUTLOOK RATING
1..100
7623
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
92
Overvalued
PROFIT vs RISK RATING
1..100
84100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3737
P/E GROWTH RATING
1..100
10049
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

COGT's Valuation (87) in the Miscellaneous industry is in the same range as FGEN (92) in the Biotechnology industry. This means that COGT’s stock grew similarly to FGEN’s over the last 12 months.

COGT's Profit vs Risk Rating (84) in the Miscellaneous industry is in the same range as FGEN (100) in the Biotechnology industry. This means that COGT’s stock grew similarly to FGEN’s over the last 12 months.

COGT's SMR Rating (100) in the Miscellaneous industry is in the same range as FGEN (100) in the Biotechnology industry. This means that COGT’s stock grew similarly to FGEN’s over the last 12 months.

COGT's Price Growth Rating (37) in the Miscellaneous industry is in the same range as FGEN (37) in the Biotechnology industry. This means that COGT’s stock grew similarly to FGEN’s over the last 12 months.

FGEN's P/E Growth Rating (49) in the Biotechnology industry is somewhat better than the same rating for COGT (100) in the Miscellaneous industry. This means that FGEN’s stock grew somewhat faster than COGT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COGTFGEN
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
84%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
86%
MACD
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
79%
Advances
ODDS (%)
Bullish Trend 11 days ago
83%
Bullish Trend 5 days ago
85%
Declines
ODDS (%)
Bearish Trend about 1 month ago
83%
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
79%
Aroon
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
70%
View a ticker or compare two or three
Interact to see
Advertisement
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
POLE10.42N/A
N/A
Andretti Acquisition Corp. II
CORT69.36-0.01
-0.01%
Corcept Therapeutics
ITGGF9.15-0.02
-0.22%
TG Holding SPA
DMYY12.23-0.14
-1.15%
dMY Squared Technology Group
OMCL32.11-1.01
-3.05%
Omnicell

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with HOFBF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then HOFBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
+0.85%
HOFBF - COGT
63%
Loosely correlated
N/A
TNFA - COGT
55%
Loosely correlated
-8.59%
IDYA - COGT
50%
Loosely correlated
+5.15%
CGON - COGT
50%
Loosely correlated
+6.88%
ATXS - COGT
50%
Loosely correlated
+7.43%
More

FGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, FGEN has been loosely correlated with AVTX. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if FGEN jumps, then AVTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FGEN
1D Price
Change %
FGEN100%
+6.98%
AVTX - FGEN
57%
Loosely correlated
+14.17%
JAGX - FGEN
32%
Poorly correlated
+7.27%
IMNM - FGEN
32%
Poorly correlated
+7.35%
COGT - FGEN
31%
Poorly correlated
+0.85%
DNTH - FGEN
31%
Poorly correlated
+7.46%
More